Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3091941
Max Phase: Preclinical
Molecular Formula: C35H45ClN6O3S3
Molecular Weight: 693.99
Molecule Type: Small molecule
Associated Items:
ID: ALA3091941
Max Phase: Preclinical
Molecular Formula: C35H45ClN6O3S3
Molecular Weight: 693.99
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCn1c(=O)/c(=C2\Sc3ccccc3N2C)s/c1=C\c1cccc[n+]1CCCCCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21.[Cl-]
Standard InChI: InChI=1S/C35H44N6O3S3.ClH/c1-3-41-30(47-32(33(41)43)34-39(2)26-15-6-7-16-27(26)46-34)22-24-14-10-13-21-40(24)20-12-5-4-11-19-36-29(42)18-9-8-17-28-31-25(23-45-28)37-35(44)38-31;/h6-7,10,13-16,21-22,25,28,31H,3-5,8-9,11-12,17-20,23H2,1-2H3,(H2-,36,37,38,42,44);1H/b34-32+;/t25-,28-,31-;/m0./s1
Standard InChI Key: LSVRDZPCAFVSJX-RDPWGNTKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 693.99 | Molecular Weight (Monoisotopic): 693.2710 | AlogP: 3.76 | #Rotatable Bonds: 14 |
Polar Surface Area: 99.35 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 13.49 | CX Basic pKa: | CX LogP: 0.95 | CX LogD: 0.95 |
Aromatic Rings: 3 | Heavy Atoms: 47 | QED Weighted: 0.14 | Np Likeness Score: -0.75 |
1. Li X, Srinivasan SR, Connarn J, Ahmad A, Young ZT, Kabza AM, Zuiderweg ER, Sun D, Gestwicki JE.. (2013) Analogs of the Allosteric Heat Shock Protein 70 (Hsp70) Inhibitor, MKT-077, as Anti-Cancer Agents., 4 (11): [PMID:24312699] [10.1021/ml400204n] |
Source(1):